Cancer Vaccines

This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vacci...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Savelyeva, Natalia. (Editor, http://id.loc.gov/vocabulary/relators/edt), Ottensmeier, Christian. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Edition:1st ed. 2017.
Series:Current Topics in Microbiology and Immunology, 405
Subjects:
Online Access:https://doi.org/10.1007/978-3-319-23910-1
LEADER 03603nam a22005295i 4500
001 978-3-319-23910-1
003 DE-He213
005 20210618043138.0
007 cr nn 008mamaa
008 170710s2017 gw | s |||| 0|eng d
020 |a 9783319239101  |9 978-3-319-23910-1 
024 7 |a 10.1007/978-3-319-23910-1  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Cancer Vaccines  |h [electronic resource] /  |c edited by Natalia Savelyeva, Christian Ottensmeier. 
250 |a 1st ed. 2017. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a VII, 210 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Topics in Microbiology and Immunology,  |x 0070-217X ;  |v 405 
505 0 |a New Approaches in Immunotherapy for the treatment of Lung Cancer -- Novel approaches for vaccination against HPV-induced cancers -- Tapping the potential of DNA Delivery with Electroporation for Cancer Immunotherapy -- Targeted immunotherapy designed to treat Muc1-expressing solid tumour -- Chimeric DNA vaccines: an effective way to overcome immune tolerance -- Linked CD4 T-cell help: broadening immune attack against cancer by vaccination -- mRNA cancer vaccines – Messages that prevail -- The Use of Anti-CD40 mAb in Cancer. 
520 |a This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment. This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs. 
650 0 |a Cancer research. 
650 0 |a Immunology. 
650 0 |a Vaccines. 
650 1 4 |a Cancer Research.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B11001 
650 2 4 |a Immunology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B14000 
650 2 4 |a Vaccine.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B16010 
700 1 |a Savelyeva, Natalia.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Ottensmeier, Christian.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319239095 
776 0 8 |i Printed edition:  |z 9783319239118 
776 0 8 |i Printed edition:  |z 9783319795522 
830 0 |a Current Topics in Microbiology and Immunology,  |x 0070-217X ;  |v 405 
856 4 0 |u https://doi.org/10.1007/978-3-319-23910-1 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)